EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access

Effects of the “AI-TA” Mobile App With Intelligent Design on Psychological and Related Symptoms of Young Survivors of Breast Cancer: Randomized Controlled Trial

Lulu Jiang iD, Jiehui Xu iD, Yanwei Wu iD, Yanyan Liu iD, Xiyi Wang iD, Yun Hu iD

JMIR mHealth and uHealth · 2024-06-04 · 12 · e50783

DOI: 10.2196/50783 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR mHealth and uHealth, published online on 2024-06-04. Written by Lulu Jiang and 5 co-authors. Institution: School of Nursing, Shanghai Jiao Tong University, Shanghai, China. Major MEDLINE topics: Mobile Applications, Breast Neoplasms, Cancer Survivors, Quality of Life. Cited 30 times so far (Crossref); 45 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Young women often face substantial psychological challenges in the initial years following cancer diagnosis, leading to a comparatively lower quality of life than older survivors. While mobile apps have emerged as potential interventions, their effectiveness remains inconclusive due to the diversity in intervention types and variation in follow-up periods. Furthermore, there is a particular dearth of evidence regarding the efficacy of these apps’ intelligent features in addressing psychological distress with these apps.

Objective

This study aims to evaluate the effectiveness of a mobile app with intelligent design called “AI-TA” on cancer-related psychological health and ongoing symptoms with a randomized controlled design.

Methods

Women aged 18 to 45 years diagnosed with breast cancer were randomly assigned to the intervention or control group. The intervention was AI-TA, which included 2-way web-based follow-up every 2 weeks. Both intention-to-treat (ITT) and per-protocol (PP) analyses employed repeated measurement analysis of variance. The participants’ background features, primary outcomes (psychological distress and frequency, self-efficacy, and social support), and secondary outcomes (quality of life) were measured using multiple instruments at 3 time points (baseline, 1-month intervention, and 3-month intervention).

Results

A total of 124 participants were randomly allocated to the control group (n=62, 50%) or intervention group (n=62, 50%). In total, 92.7% (115/124) of the participants completed the intervention. Significant improvements in psychological symptoms (Memorial Symptom Assessment Scale-Short Form) were observed in the ITT group from baseline to 1-month intervention relative to the control group (ITT vs control: 1.17 vs 1.23; P

Subjects

MeSH terms (MEDLINE)

Mobile ApplicationsBreast NeoplasmsCancer SurvivorsQuality of LifeHumansFemaleAdultMiddle AgedAdolescentSurveys and QuestionnairesSelf Efficacy

Author keywords

artificial intelligencebreast cancerinteractivitymobile apppsychological symptomsquality of lifeself-efficacysocial support

Authors and institutions

  • School of Nursing, Shanghai Jiao Tong University, Shanghai, China.
  • Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID profiles: Lulu Jiang, Jiehui Xu, Yanwei Wu, Yanyan Liu, Xiyi Wang, Yun Hu

Cite

APA

Jiang, L., Xu, J., Wu, Y., Liu, Y., Wang, X., & Hu, Y. (2024). Effects of the “AI-TA” Mobile App With Intelligent Design on Psychological and Related Symptoms of Young Survivors of Breast Cancer: Randomized Controlled Trial. JMIR mHealth and uHealth, 12, e50783. https://doi.org/10.2196/50783

Vancouver

Jiang L, Xu J, Wu Y, Liu Y, Wang X, Hu Y. Effects of the “AI-TA” Mobile App With Intelligent Design on Psychological and Related Symptoms of Young Survivors of Breast Cancer: Randomized Controlled Trial. JMIR mHealth and uHealth. 2024;12:e50783. doi:10.2196/50783

BibTeX
@article{Jiang2024,
  author = {Jiang, Lulu and Xu, Jiehui and Wu, Yanwei and Liu, Yanyan and Wang, Xiyi and Hu, Yun},
  title = {Effects of the “AI-TA” Mobile App With Intelligent Design on Psychological and Related Symptoms of Young Survivors of Breast Cancer: Randomized Controlled Trial},
  journal = {JMIR mHealth and uHealth},
  year = {2024},
  volume = {12},
  pages = {e50783},
  doi = {10.2196/50783}
}
Start for free →